Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa

World Journal of Gastroenterology

Volumn 12, Issue 13, 2006, Pages 2109-2114

  Griniatsos, John ^a,b   Michail, Othon P ^a   Theocharis, Stamatios ^a   Arvelakis, Antonios ^a   Papaconstantinou, Ioannis ^a   Felekouras, Evangelos ^a   Pikoulis, Emmanouel ^a   Karavokyros, Ioannis ^a   Bakoyiannis, Chris ^a   Marinos, George ^a   Bramis, John ^a   Michail, Panayiotis O ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

CDK inhibitors; Cell proliferation; Circadian rhythm; G1 phase proteins

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; PROTEIN P16INK4A;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COLOSTOMY; CORRELATION ANALYSIS; DRUG EFFICACY; EMBEDDING; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE CELL; MALE; MULTIMODALITY CANCER THERAPY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REACTION TIME; RECTUM CARCINOMA; RECTUM MUCOSA;

EID: 33646439163     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i13.2109     Document Type: Article

References (53)

1. Donjerkovic D, Scott DW. Regulation of the G1 phase of the mammalian cell cycle. Cell Res 2000; 10: 1-16
2. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512
3. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13: 261-291
4. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065
5. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582
6. Pardee AB. G1 events and regulation of cell proliferation. Science 1989; 246: 603-608
7. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993; 7: 812-821
8. Murray A, Hunt T. The Cell Cycle. Oxford, Oxford University Press, 1993.
9. Miller ME, Cross FR. Cyclin specificity: how many wheels do you need on a unicycle? J Cell Sci 2001; 114: 1811-1820
10. Swanton C. Cell-cycle targeted therapies. Lancet Oncol 2004; 5: 27-36
11. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci U S A 1994; 91: 5291-5295
12. Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Slingerland J. G1 control in mammalian cells. J Cell Sci Suppl 1994; 18: 69-73
13. Pittendrigh CS. Temporal organization: reflections of a Darwinian clock-watcher. Annu Rev Physiol 1993; 55: 16-54
14. Dunlap JC. Molecular bases for circadian clocks. Cell 1999; 96: 271-290
15. Scheving LA. Chronobiology of cell proliferation in mammals: implications for basic research and cancer chemotherapy. In Edmunds LN (ed). Cell Cycle Clocks, New York, Marcel Dekker 1984: 455-499
16. Scheving LE, Burns ER, Pauly JE, Tsai TH. Circadian variation in cell division of the mouse alimentary tract, bone marrow and corneal epithelium. Anat Rec 1978; 191: 479-486
17. Scheving LE, Tsai TH, Scheving LA. Chronobiology of the intestinal tract of the mouse. Am J Anat 1983; 168: 433-465
18. Buchi KN, Moore JG, Hrushesky WJ, Sothern RB, Rubin NH. Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 1991; 101: 410-415
19. Marra G, Anti M, Percesepe A, Armelao F, Ficarelli R, Coco C, Rinelli A, Vecchio FM, D'Arcangelo E. Circadian variations of epithelial cell proliferation in human rectal crypts. Gastroenterology 1994; 106: 982-987
20. Bjarnason GA, Hrushesky WJ. Cancer Chronotherapy. In Hrushesky WJM (ed): Circadian Cancer Therapy. Boca Raton, CRC Press 1994: 241-263
21. Hrushesky WJ, Bjarnason GA. Circadian cancer therapy. J Clin Oncol 1993; 11: 1403-1417
22. Bjarnason GA, Jordan RC, Sothern RB. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol 1999; 154: 613-622
23. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 1996; 110: 669-674
24. Ahn MJ, Kim BH, Jang SJ, Hong EK, Lee WM, Baik HK, Park HK, Lee CB, Ki M. Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance. J Korean Med Sci 1998; 13: 513-518
25. Brandi G, Calabrese C, Pantaleo MA, Morselli Labate A, Di Febo G, Hakim R, De Vivo A, Di Marco MC, Biasco G. Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. Cancer Lett 2004; 208: 193-196
26. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997; 3: 222-225
27. Maurer HR. Potential pitfalls of [3H]thymidine techniques to measure cell proliferation. Cell Tissue Kinet 1981; 14: 111-120
28. Bjarnason GA, Jordan R. Rhythms in human gastrointestinal mucosa and skin. Chronobiol Int 2002; 19: 129-140
29. Arber N, Hibshoosh H, Yasui W, Neugut AI, Hibshoosh A, Yao Y, Sgambato A, Yamamoto H, Shapira I, Rosenman D, Fabian I, Weinstein IB, Tahara E, Holt PR. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 1999; 8: 1101-1105
30. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 2002; 1602: 73-87
31. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001; 1: 222-231
32. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995; 15: 2612-2624
33. Chang ZF, Huang DY, Lai TC. Different regulation of the human thymidine kinase promoter in normal human diploid IMR-90 fibroblasts and HeLa cells. J Biol Chem 1995; 270: 27374-27379
34. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995; 15: 4215-4224
35. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86: 617-621
36. Demetrick DJ, Matsumoto S, Hannon GJ, Okamoto K, Xiong Y, Zhang H, Beach DH. Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p2l (CDKN1) and KAP (CDKN3). Cytogenet Cell Genet 1995; 69: 190-192
37. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T, Nakano H. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 1998; 82: 1238-1243
38. Wang A, Yoshimi N, Suzui M, Yamauchi A, Tarao M, Mori H. Diaferent expression patterns of cyclins A, D1 and E in human colorectal cancer. J Cancer Res Clin Oncol 1996; 122: 122-126
39. Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP, Forrester K, Gerwin B, Serrano M, Beach DH. Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A 1994; 91: 11045-11049
40. Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 1995; 267: 249-252
41. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993; 366: 704-707
42. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756
43. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, 3rd, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440
44. Dai CY, Furth EE, Mick R, Koh J, Takayama T, Niitsu Y, Enders GH. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology 2000; 119: 929-942
45. Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003; 9: 2202-2206
46. Tada T, Watanabe T, Kazama S, Kanazawa T, Hata K, Komuro Y, Nagawa H. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers. Hepatogastroenterology 2003; 50: 1756-1760
47. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11: 847-862
48. Archer SY, Johnson JJ, Kim HJ, Hodin RA. p2l gene regulation during enterocyte differentiation. J Surg Res 2001; 98: 4-8
49. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816
50. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994; 9: 3389-3396
51. Coudert B, Bjarnason G, Focan C, di Paola ED, Levi F. It is time for chronotherapy! Pathol Biol (Paris) 2003; 51: 197-200
52. Eriguchi M, Levi F, Hisa T, Yanagie H, Nonaka Y, Takeda Y. Chronotherapy for cancer. Biomed Pharmacother 2003; 57 Suppl 1: 92s-95s
53. Vincenzi B, Santini D, La Cesa A, Tonini G. Cancer chronotherapy: principles, applications, and perspectives. Cancer 2003; 98: 881-882; author reply 882-883